 |
市場調查報告書
商品編碼
2066982
全球體外毒性測試市場：依產品、類型、毒性終點和測試方法、技術、方法論、最終用戶和地區分類－預測至2031年In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031 |
||||||
價格
預計體外毒性測試市場將從 2026 年的 126.9 億美元成長到 2031 年的 209.7 億美元，預測期內複合年成長率為 10.6%。
這一成長是由細胞檢測、3D培養模型、類器官、晶片器官系統、高內涵篩檢、自動化和人工智慧驅動的預測毒理學在早期化合物篩檢和安全性分析中日益廣泛的應用所推動的。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 計算單位 | 金額（10億美元） |
| 部分 | 按產品、類型、毒性終點和測試、技術、方法、最終用戶、地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
製藥和生物技術領域研發支出的增加、對更快、更貼近人體毒性預測的需求、外包給合約研究組織 (CRO) 以及旨在減少動物試驗並改進臨床前決策的監管舉措，都進一步推動了這一市場的發展。
“到2025年，產品領域的市場佔有率將大於服務領域。”
在體外毒性測試市場中，產品板塊佔據了最大的市場佔有率。產品板塊之所以能夠推動市場成長，是因為體外毒理學工作流程高度依賴可重複使用的產品，例如檢測試劑盒、試劑、細胞培養基、血清、緩衝液、微孔盤、檢測基材、參考標準品和檢驗的細胞模型。與服務不同，這些產品在所有細胞毒性、遺傳毒性、器官毒性、經皮毒性、眼毒性和機制毒性測試中都需要重複使用。
“到2025年，北美將主導體外毒性測試市場。”
到2025年，北美將主導體外毒性測試市場。這主要歸功於北美強大的製藥和生物技術公司網路、先進的合約研究組織（CRO）基礎設施、資金雄厚的學術研究中心，以及美國和加拿大對非動物安全性測試技術的早期應用。該地區對藥物發現、臨床前開發、化妝品安全性評估、化學品評估和醫療設備生物相容性測試等領域的細胞毒性、基因毒性、肝毒性、心臟毒性和基於機制的毒性測試的需求日益成長。此外，美國擁有成熟的檢測試劑盒供應商、細胞模型提供者、晶片器官公司、高內涵篩檢平台和預測毒理學軟體開發商等生態系統，為體外毒理學產品和服務的廣泛商業化提供了支持。鼓勵採用動物試驗替代方法的監管現代化措施也進一步推動了這些方法的應用。
本報告涵蓋的公司簡介清單：
- 賽默飛世爾科技公司（美國）
- 默克集團（德國）
- Eurofins Scientific（盧森堡）
- 美國實驗室控股公司（美國）
- 查爾斯河實驗室（美國）
- SGS SA（瑞士）
- Bio-Rad Laboratories, Inc.（美國）
- Evotec SE（德國）
- Promega公司（美國）
- Catalent公司（美國）
- 安捷倫科技公司（美國）
- IntertekGroup Limited（英國）
- Revvity（美國）
- Inotiv（美國）
- BioIVT（美國）
- 隆札（瑞士）
- Creative Biolabs（美國）
- 上海美迪西隆股份有限公司（中國）
- Creative Bioarray（美國）
- Aragen生命科學有限公司（印度）
- Enzo Biochem Inc.（美國）
- Microbac Laboratories, Inc.（美國）
- Vimta Labs Ltd.（印度）
- Pacific BioLabs Inc.（美國）
- MB 研究實驗室（美國）
調查範圍：
本研究報告按產品、類型、毒性終點和測試、技術、方法、最終用戶和地區對體外毒性測試市場進行細分。
本報告詳細介紹了影響體外毒性測試市場成長的關鍵因素（促進因素、趨勢、挑戰、機會等）。該報告對主要產業參與企業進行了全面分析，深入剖析了他們的業務概況、產品、關鍵策略、夥伴關係和協議。此外，報告還涵蓋了體外毒性測試市場的最新動態，例如新產品發布、併購等。
購買本報告的主要好處：
本報告對體外毒性測試市場及其細分市場的整體收入進行了最精準的估算，為市場領導者和新參與企業提供支援。報告也有助於相關人員深入了解競爭格局，最佳化業務定位，並制定合適的打入市場策略。透過本報告，相關人員可以掌握市場趨勢，並獲取有關關鍵市場促進因素、限制因素、機會和挑戰的資訊。
本報告深入分析了以下幾點：
- 本分析檢視了影響市場成長的因素，包括關鍵促進因素（產業轉向非動物毒性測試方法和加速的技術進步）、阻礙因素（複雜終點的體內和體外研究相關性的局限性）、機會（人工智慧/機器學習驅動的預測毒理學、越來越重視使用體外方法進行藥物發現以及對大麻、電子菸和新產品進行安全測試）和挑戰（人工智慧主導的毒理學和挑戰中的人工智慧和挑戰（人工智慧驅動的毒理學和挑戰）。
- 產品與服務開發與創新：深入了解體外毒性測試市場中新推出的產品與服務。
- 市場開發：提供各地區盈利市場的全面資訊。
- 市場多元化：提供有關體外毒性測試市場的新產品、未開發的市場、近期趨勢和投資的全面資訊。
- 競爭分析：市場主要參與者包括：賽默飛世爾科技公司（美國）、默克集團（德國）、歐陸科技（盧森堡）、美國實驗室控股公司（美國）、查爾斯河實驗室（美國）、SGS SA（瑞士）、Bio-Rad Laboratories, Inc.（美國）、Evotec SE（德國）、Prome Corporation、Bio-Rad Laboratories, Inc.（美國）、Evotec SE（德國科技公司）、Interme Corporation（美國）、Interent）、美國科技公司、美國科技公司（美國） plc（英國）、Revvity（美國）、Inotiv（美國）、BioIVT（美國）、龍沙（瑞士）、Creative Biolabs（美國）、上海美迪康生物科技有限公司（中國）、Creative Bioarray（美國）、Aragen Life Sciences Ltd.（印度）、Enzo Biochem Inc.（美國）、Mic Ltd Laborator）、美國（印度） Inc.（美國）、MB Research Laboratories（美國）。以及其他。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 宏觀經濟展望
- 價值鏈分析
- 生態系分析
- 價格分析
- 重要會議和活動
- 影響我們客戶公司業務的趨勢/變化
- 投資及資金籌措活動
- 2025年關稅對體外毒性測試市場的影響
第6章：技術進步、人工智慧的影響、專利、創新與未來應用
- 主要技術
- 鄰近技術
- 互補技術
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/生成式人工智慧對體外毒性測試市場的影響
第7章永續性和監管情勢
- 當地法規和合規性
- 對永續性和監管政策舉措的影響
- 認證、標籤檢視和環境標準
第8章：顧客趨勢與購買行為
- 決策流程
- 買方相關人員和採購評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業中尚未滿足的需求
- 市場盈利
第9章：體外毒性測試市場（依產品/服務分類）
- 產品
- 服務
第10章：體外毒性測試產品市場（按類型分類）
- 試劑和耗材
- 檢測試劑盒
- 裝置
- 軟體與資訊學
第11章：體外毒性測試產品市場（依毒性終點和測試方法分類）
- 器官毒性試驗
- 細胞毒性試驗
- 皮膚毒性、皮膚刺激性、腐蝕性和致敏性
- 基因毒性測試
- 氧化壓力及其毒性機制
- 其他
第12章：體外毒性測試產品市場（依技術分類）
- 細胞培養技術
- 高通量、高內涵技術
- 器官類型和微生理技術
- 體學技術
- 其他
第13章：體外毒性測試產品市場（依方法論分類）
- 基於細胞的毒性測試
- 生化毒性測試方法
- 基於分子和體學的毒理學分析方法
- 基於體外模型的毒性測試方法
- In Silico/計算毒性測試方法
- 其他
第14章：體外毒性測試產品市場（依最終用戶分類）
- 製藥和生物技術公司
- 消費者關懷公司
- 研究與開發合約組織
- 學術和研究機構
- 食品和飲料公司
- 其他
第15章：體外毒性測試服務市場（按類型分類）
- 毒理學檢測服務
- 生物模型和檢測方法開發服務
- 影像處理和分析毒理學服務
- 數據分析、生物資訊學和預測毒理學
第16章：體外毒性測試服務市場（依方法論分類）
- 基於細胞的毒性測試服務
- 生化毒性測試服務
- In Silico/基於電腦的毒性測試服務
- 分子生物學和體學毒理學服務
- 體外模型毒性測試服務
- 其他
第17章：體外毒性測試服務市場（依最終用戶分類）
- 製藥和生物技術公司
- 消費者關懷公司
- 食品和飲料公司
- 學術和研究機構
- 其他
第18章：體外毒性測試市場（依地區分類）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東
- 海灣合作理事會國家
- 非洲
第19章 競爭情勢
- 概述
- 主要參與企業的策略/優勢
- 所得分配分析
- 市佔率分析
- 企業估值矩陣：主要公司，2025 年
- 公司估值矩陣：新創企業/中小企業，2025 年
- 企業估值和財務指標
- 品牌/產品對比
- 競爭格局
第20章：公司簡介
- 主要參與企業
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGAA
- EUROFINS SCIENTIFIC
- CHARLES RIVER LABORATORIES
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- SGS SA
- LONZA
- REVVITY
- BIO-RAD LABORATORIES, INC.
- EVOTEC SE
- NOVO HOLDINGS
- INTERTEK GROUP PLC
- INOTIV
- PROMEGA CORPORATION
- 其他公司
- BIOIVT
- CREATIVE BIOLABS
- MEDICILON
- CREATIVE BIOARRAY
- ARAGEN LIFE SCIENCES LTD.
- ENZO BIOCHEM INC.
- MICROBAC LABORATORIES, INC.
- VIMTA LABS LTD.
- PACIFIC BIOLABS, INC.
- MB RESEARCH LABORATORIES
第21章調查方法
第22章附錄
Product Code: BT 2373
The in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing from an estimated USD 12.69 billion in 2026, at a CAGR of 10.6% during the forecast period. Growth is being driven by increasing use of cell-based assays, 3D culture models, organoids, organ-on-chip systems, high-content screening, automation, and AI-enabled predictive toxicology for early-stage compound screening and safety profiling.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Product, Type, Method, End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
The market is further supported by rising pharmaceutical and biotechnology R&D spending, demand for faster and more human-relevant toxicity prediction, outsourcing to CROs, and regulatory momentum to reduce animal testing while improving preclinical decision-making.
"The products segment accounted for a larger share than the services segment in 2025."
By offering, the products segment accounted for the largest share in the global in vitro toxicology testing market. The products segment led the market because in vitro toxicology workflows depend heavily on recurring product consumption, including assay kits, reagents, cell culture media, sera, buffers, microplates, detection substrates, reference standards, and validated cell models. Unlike services, these products are repeatedly required across every cytotoxicity, genotoxicity, organ toxicity, dermal, ocular, and mechanistic toxicity study.
"North America dominated the in vitro toxicology testing market in 2025."
North America dominated the in vitro toxicology testing market in 2025, primarily due to the strong presence of pharmaceutical and biotechnology companies, advanced CRO infrastructure, well-funded academic research centers, and early adoption of non-animal safety testing technologies across the US and Canada. The region has high demand for cytotoxicity, genotoxicity, hepatotoxicity, cardiotoxicity, and mechanistic toxicity testing during drug discovery, preclinical development, cosmetics safety assessment, chemical evaluation, and medical device biocompatibility testing. The US also has a mature ecosystem of assay kit suppliers, cell model providers, organ-on-chip companies, high-content screening platforms, and predictive toxicology software developers, supporting broad commercialization of in vitro toxicology products and services. Regulatory modernization initiatives encouraging alternative methods to animal testing further support adoption.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side - 70%; Demand Side 30%
- By Designation: Managers - 45%; CXO & Directors - 30%; and Executives - 25%
- By Region: North America - 40%; Europe - 25%; Asia Pacific - 20%; Latin America - 10%; and Middle East & Africa - 5%
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- Eurofins Scientific (Luxembourg)
- Laboratory Corporation of America Holdings (US)
- Charles River Laboratories (US)
- SGS SA (Switzerland)
- Bio-Rad Laboratories, Inc. (US)
- Evotec SE (Germany)
- Promega Corporation (US)
- Catalent, Inc. (US)
- Agilent Technologies, Inc. (US)
- Intertek Group plc (UK)
- Revvity (US)
- Inotiv (US)
- BioIVT (US)
- Lonza (Switzerland)
- Creative Biolabs (US)
- Shanghai Medicilon Inc. (China)
- Creative Bioarray (US)
- Aragen Life Sciences Ltd. (India)
- Enzo Biochem Inc. (US)
- Microbac Laboratories, Inc. (US)
- Vimta Labs Ltd. (India)
- Pacific BioLabs Inc. (US)
- MB Research Laboratories (US)
Research Coverage:
This research report categorizes the in vitro toxicology testing market by offering {Products [Reagents & Consumables (Cell Lines & Primary Cells, Culture Reagents, Media & Consumables, 3D Models and Tissue Systems, Other Reagents & Consumables), Assay Kits (Cytotoxicity Assay, Genotoxicity Assay, Organ-Specific Toxicity Assay, Other Assays), Equipment (Detection, Imaging & Analytical Systems (Imaging Systems, Detection Instruments, Other Instruments), Liquid Handling & Automation Systems, Other Equipment), Software & Informatics, and Services; Product - By Toxicity End Point (Organ Toxicity Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity and Skin Irritation, Corrosion and Sensitization, Oxidative Stress and Mechanistic Toxicity, Other Toxicity Endpoints and Tests); Product - By Technology (Cell Culture Technologies, High-Throughput and High-Content Technologies, Omics Technologies, Organotypic and Microphysiological Based Technologies, Other Technologies); Product - By Method (Cell-Based Toxicity Testing Method, Biochemical Toxicity Testing Method, In Silico/Computational Toxicity Testing Method, Ex Vivo Models-Based Toxicity Testing Method, Molecular & Omics-Based Toxicology Method, Other Methods); Product - By End User (Pharmaceuticals & Biotechnology Companies, Consumer Care Companies, Food & Beverages Companies, Cros, Academic And Research Institutes, Other End Users); Service- By Type (Toxicology Testing Service, Biological Model And Assay Development Services, Imaging And Analytical Toxicology Services, Data Analysis, Bioinformatics, And Predictive Toxicology); Service - By Method (Cell-Based Toxicity Testing Method, Biochemical Toxicity Testing Method, In Silico/Computational Toxicity Testing Method, Ex Vivo Models-Based Toxicity Testing Method, Molecular & Omics-Based Toxicology Method, Other Methods); Service - By End User (Pharmaceuticals & Biotechnology Companies, Consumer Care Companies, Food & Beverages Companies, Academic And Research Institutes, Other End Users).
The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the in vitro toxicology testing market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the in vitro toxicology testing market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall in vitro toxicology testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (Growing industry shift toward non-animal toxicology testing methods, increasing technological advancements), restraints (Limited in vivo-to-in vitro correlation for complex endpoints), opportunities (AI/ML-powered predictive toxicology, increasing focus on drug discovery using in vitro methods, cannabis, e-cigarette, and novel product safety testing), and challenges (Ethical and regulatory challenges in AI-driven toxicology), influencing the growth of the market
- Product/Service Development/Innovation: Detailed insights on newly launched products/services of the in vitro toxicology testing market
- Market Development: Comprehensive information about lucrative markets across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the in vitro toxicology testing market
- Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), Charles River Laboratories (US), SGS SA (Switzerland), Bio-Rad Laboratories, Inc. (US), Evotec SE (Germany), Promega Corporation (US), Catalent, Inc. (US), Agilent Technologies, Inc. (US), Intertek Group plc (UK), Revvity (US), Inotiv (US), BioIVT (US), Lonza (Switzerland), Creative Biolabs (US), Shanghai Medicilon Inc. (China), Creative Bioarray (US), Aragen Life Sciences Ltd. (India), Enzo Biochem Inc. (US), Microbac Laboratories, Inc. (US), Vimta Labs Ltd. (India), Pacific BioLabs Inc. (US), and MB Research Laboratories (US), among others, in the market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
- 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
- 3.2 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE
- 3.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET SHARE, BY END USER, 2026 VS 2031 (%)
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growing Industry Shift Toward Non-Animal Toxicology Testing Methods
- 4.2.1.2 Increasing Technological Advancements
- 4.2.1.3 Rising Pharmaceutical R&D Expenditure and Drug Attrition Costs
- 4.2.2 RESTRAINTS
- 4.2.2.1 Limited In Vivo-to-In Vitro Correlation for Complex Endpoints
- 4.2.2.2 High Cost of Advanced Platforms (Organ-on-Chip, 3D Models)
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 AI/ML-Powered Predictive Toxicology
- 4.2.3.2 Increasing Focus on Drug Discovery Using In Vitro Methods
- 4.2.3.3 Cannabis, E-Cigarette, and Novel Product Safety Testing
- 4.2.4 CHALLENGES
- 4.2.4.1 Ethical and Regulatory Challenges in AI-Driven Toxicology
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2025
- 5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025
- 5.6 KEY CONFERENCES & EVENTS
- 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.8 INVESTMENT/FUNDING ACTIVITY
- 5.9 IMPACT OF 2025 TARIFFS-IN VITRO TOXICOLOGY TESTING MARKET
- 5.9.1 INTRODUCTION
- 5.9.2 KEY TARIFF RATES
- 5.9.3 PRICE IMPACT ANALYSIS
- 5.9.4 IMPACT ON COUNTRIES/REGIONS
- 5.9.4.1 North America
- 5.9.4.2 Europe
- 5.9.4.3 Asia Pacific
- 5.9.5 IMPACT ON END-USE INDUSTRIES
- 5.9.5.1 Pharmaceutical and biotechnology companies
- 5.9.5.2 CROs
- 5.9.5.3 Academic & Research Institutes
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY TECHNOLOGIES
- 6.1.1 CELL CULTURE TECHNOLOGIES
- 6.1.2 OMICS TECHNOLOGIES
- 6.2 ADJACENT TECHNOLOGIES
- 6.2.1 COMPUTATIONAL TOXICOLOGY AND AI
- 6.3 COMPLEMENTARY TECHNOLOGIES
- 6.3.1 LAB-ON-A-CHIP (LOC)/ORGAN-ON-A-CHIP (OOC) SYSTEMS
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015-2025
- 6.6 FUTURE APPLICATIONS
- 6.7 IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET
- 6.7.1 TOP USE CASES AND MARKET POTENTIAL
- 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET
- 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.7.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
- 7.1.3 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
- 7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING
- 9.1 INTRODUCTION
- 9.2 PRODUCTS
- 9.2.1 GROWING ADOPTION OF ADVANCED ASSAY PRODUCTS TO SUPPORT GROWTH
- 9.3 SERVICES
- 9.3.1 INCREASING FOCUS ON OUTSOURCING TOXICOLOGY TO AID GROWTH
10 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE
- 10.1 INTRODUCTION
- 10.2 REAGENTS & CONSUMABLES
- 10.2.1 CULTURE REAGENTS, MEDIA, AND CONSUMABLES
- 10.2.1.1 Increasing adoption of IVTT workflows and recurring use of reagents to support growth
- 10.2.2 3D MODELS & TISSUE SYSTEMS
- 10.2.2.1 Support from regulatory agencies and wide usage to drive market growth
- 10.2.3 CELL LINES & PRIMARY CELLS
- 10.2.3.1 Emphasis on personalized medicine and driving quality improvement in commercially available cells to propel market
- 10.2.4 OTHER REAGENTS & CONSUMABLES
- 10.2.1 CULTURE REAGENTS, MEDIA, AND CONSUMABLES
- 10.3 ASSAY KITS
- 10.3.1 ORGAN-SPECIFIC TOXICITY ASSAYS
- 10.3.1.1 Market is driven well-documented failure of generic cytotoxicity screens to predict organ-level adverse effects
- 10.3.2 CYTOTOXICITY ASSAYS
- 10.3.2.1 Cytotoxicity assays are the most universally applied assays in IVTT
- 10.3.3 GENOTOXICITY ASSAYS
- 10.3.3.1 Stringent regulatory mandates to support growth
- 10.3.4 OTHER ASSAYS
- 10.3.1 ORGAN-SPECIFIC TOXICITY ASSAYS
- 10.4 EQUIPMENT
- 10.4.1 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS
- 10.4.1.1 Detection instruments
- 10.4.1.1.1 Growth is supported by the increasing volume of HTS workflows in pharmaceutical R&D and expanding use of functional safety pharmacology assays
- 10.4.1.2 Imaging systems
- 10.4.1.2.1 Demand for imaging systems in IVTT is being driven by the transition from single-endpoint to multiparametric, image-based toxicity assessment
- 10.4.1.3 Other instruments
- 10.4.1.4 Liquid handling & automation systems
- 10.4.1.4.1 Ease offered by automation and the important role of liquid handling in workflow to aid growth
- 10.4.1.5 Other instruments
- 10.4.1.1 Detection instruments
- 10.4.1 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS
- 10.5 SOFTWARE & INFORMATICS
- 10.5.1 DEMAND FOR AI/ML CAPABILITIES WITH TOXICOLOGY DATA TO DRIVE GROWTH
11 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST
- 11.1 INTRODUCTION
- 11.2 ORGAN TOXICITY TESTING
- 11.2.1 HEPATOTOXICITY
- 11.2.1.1 Regulatory mandates and focus on developing advanced liver models to support growth
- 11.2.2 OCULAR TOXICITY
- 11.2.2.1 Demand for cosmetics application to aid growth
- 11.2.3 CARDIOTOXICITY
- 11.2.3.1 Regulatory imperative for comprehensive cardiac safety profiling to drive growth
- 11.2.4 NEUROTOXICITY
- 11.2.4.1 Focus on developmental neurotoxicity and the expanding CNS drug pipelines to support growth
- 11.2.5 OTHER TOXICITY END POINTS
- 11.2.1 HEPATOTOXICITY
- 11.3 CYTOTOXICITY TESTING
- 11.3.1 A GROWING NUMBER OF NEW CLINICAL ENTITIES AND THE EXPANSION OF HTS PROGRAMS DRIVES MARKET
- 11.4 DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION
- 11.4.1 RISING AWARENESS AND BAN ON ANIMAL TESTING TO PROPEL MARKET
- 11.5 GENOTOXICITY TESTING
- 11.5.1 MANDATORY REQUIREMENT IN DRUG APPLICATIONS SUPPORTS MARKET GROWTH
- 11.6 OXIDATIVE STRESS AND MECHANISTIC TOXICITY
- 11.6.1 SHIFT TOWARD MECHANISTIC UNDERSTANDING TO DRIVE DEMAND FOR ASSAYS
- 11.7 OTHER TOXICITY ENDPOINTS & TESTS
12 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY
- 12.1 INTRODUCTION
- 12.2 CELL CULTURE TECHNOLOGIES
- 12.2.1 ADVANCING ADOPTION OF HUMAN-RELEVANT CELL CULTURE MODELS TO SUPPORT MARKET GROWTH
- 12.3 HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES
- 12.3.1 EXPANDING HIGH-THROUGHPUT TOXICITY SCREENING TO ACCELERATE EARLY SAFETY ASSESSMENT
- 12.4 ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES
- 12.4.1 GROWING FOCUS ON HUMAN-RELEVANT TOXICITY PREDICTION TO SUPPORT GROWTH
- 12.5 OMICS TECHNOLOGIES
- 12.5.1 INCREASING INTEGRATION OF OMICS-BASED TOXICOLOGY TO IMPROVE MECHANISTIC RISK ASSESSMENT
- 12.6 OTHER TECHNOLOGIES
13 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD
- 13.1 INTRODUCTION
- 13.2 CELL-BASED TOXICITY TESTING
- 13.2.1 CELL-BASED TOXICITY TESTING HOLDS LARGEST MARKET SHARE
- 13.3 BIOCHEMICAL TOXICITY TESTING METHOD
- 13.3.1 SPEED AND REPRODUCIBILITY TO AID GROWTH
- 13.4 MOLECULAR & OMICS-BASED TOXICOLOGY METHOD
- 13.4.1 TRANSITION FROM SINGLE-ENDPOINT TO SYSTEMS-LEVEL TOXICOLOGICAL ASSESSMENT DRIVES DEMAND GROWTH
- 13.5 EX VIVO MODEL-BASED TOXICITY TESTING METHOD
- 13.5.1 INCREASING AVAILABILITY OF HUMAN DONOR TISSUE TO SUPPORT ADOPTION
- 13.6 IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD
- 13.6.1 ESCALATING COST AND TIME PRESSURES OF PHYSICAL TESTING TO AID GROWTH
- 13.7 OTHER METHODS
14 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER
- 14.1 INTRODUCTION
- 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.2.1 RISING GLOBAL PHARMACEUTICAL R&D EXPENDITURE SUPPORTING DRUG DISCOVERY EFFORTS
- 14.3 CONSUMER CARE COMPANIES
- 14.3.1 ANIMAL TESTING BANS TO SUPPORT SEGMENT GROWTH
- 14.4 CROS
- 14.4.1 HIGH CAPITAL AND OPERATIONAL COSTS OF MAINTAINING ADVANCED TECHNOLOGIES SUPPORT OUTSOURCING TO CROS
- 14.5 ACADEMIC & RESEARCH INSTITUTES
- 14.5.1 INCREASING GOVERNMENT FUNDING FOR ALTERNATIVE TESTING RESEARCH TO AID GROWTH
- 14.6 FOOD & BEVERAGE COMPANIES
- 14.6.1 GROWTH OF FUNCTIONAL FOODS, PLANT-BASED PROTEINS, AND NOVEL INGREDIENTS DRIVES DEMAND FOR TESTING
- 14.7 OTHER END USERS
15 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE
- 15.1 INTRODUCTION
- 15.2 TOXICOLOGY TESTING SERVICES
- 15.2.1 ORGAN-SPECIFIC TOXICITY SERVICES
- 15.2.1.1 High reliance on outsourced services and growing demand for cardiotoxicity testing to drive market
- 15.2.2 CYTOTOXICITY TESTING SERVICES
- 15.2.2.1 Growing preclinical pipelines requiring cytotoxicity testing to propel demand
- 15.2.3 GENOTOXICITY TESTING SERVICES
- 15.2.3.1 Expanding impurity testing obligations to drive market
- 15.2.4 OTHER TOXICITY TESTING SERVICES
- 15.2.1 ORGAN-SPECIFIC TOXICITY SERVICES
- 15.3 BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES
- 15.3.1 STRONG GROWTH SUPPORTED BY RISING DEMAND FOR APPLICATION-SPECIFIC MODELS AND ASSAYS
- 15.4 IMAGING & ANALYTICAL TOXICOLOGY SERVICES
- 15.4.1 CAPITAL-INTENSIVE INSTRUMENTATION AND SPECIALIZED REQUIREMENTS SUPPORT OUTSOURCING
- 15.5 DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY
- 15.5.1 INTEGRATION OF AI/ML AND RISING DATA COMPLEXITY PROPEL DEMAND
16 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD
- 16.1 INTRODUCTION
- 16.2 CELL-BASED TOXICITY TESTING SERVICES
- 16.2.1 HIGH COST AND COMPLEXITY OF MAINTAINING ADVANCED CELL CULTURE INFRASTRUCTURE TO DRIVE GROWTH
- 16.3 BIOCHEMICAL TOXICITY TESTING SERVICES
- 16.3.1 GROWTH OF BIOLOGIC DRUG DEVELOPMENT IS DRIVING DEMAND FOR SPECIALIZED BIOCHEMICAL IMMUNOGENICITY TESTING SERVICES
- 16.4 IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES
- 16.4.1 GROWING DATA COMPLEXITY, AI/ML MATURITY, AND REGULATORY ACCEPTANCE DRIVE GROWTH
- 16.5 MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES
- 16.5.1 SPECIALIZED ANALYTICAL EXPERTISE REQUIREMENTS RELATED TO OMICS TO DRIVE GROWTH
- 16.6 EX VIVO MODEL-BASED TOXICITY TESTING SERVICES
- 16.6.1 USE OF EX VIVO MODELS FOR IN VITRO AND IN SILICO VALIDATION TO SUPPORT GROWTH
- 16.7 OTHER SERVICES
17 IN VITRO TOXICOLOGY TESTING SERVICE MARKET, BY END USER
- 17.1 INTRODUCTION
- 17.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 17.2.1 INCREASING COST AND COMPLEXITY OF MAINTAINING ADVANCED IVTT PLATFORMS IN-HOUSE TO SUPPORT GROWTH
- 17.3 CONSUMER CARE COMPANIES
- 17.3.1 REGULATION MANDATING IN VITRO-ONLY SAFETY ASSESSMENT IS SUPPORTING GROWTH
- 17.4 FOOD & BEVERAGE COMPANIES
- 17.4.1 EXPANDING SCOPE OF FUNCTIONAL FOOD AND ALTERNATIVE PROTEIN SAFETY ASSESSMENT TO SUPPORT GROWTH
- 17.5 ACADEMIC & RESEARCH INSTITUTES
- 17.5.1 OUTSOURCING OF SPECIALIZED SERVICES TO SUPPORT GROWTH
- 17.6 OTHER END USERS
18 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
- 18.1 INTRODUCTION
- 18.2 NORTH AMERICA
- 18.2.1 US
- 18.2.1.1 Growing focus on biomarker discovery and research in structure-based drug design to propel the market
- 18.2.2 CANADA
- 18.2.2.1 Strong support for R&D in pharmaceuticals and proteomics to boost market growth
- 18.2.1 US
- 18.3 EUROPE
- 18.3.1 GERMANY
- 18.3.1.1 Well-established pharmaceuticals industry to support market growth
- 18.3.2 UK
- 18.3.2.1 Rising focus on research activities and academia-industry partnerships to drive market
- 18.3.3 FRANCE
- 18.3.3.1 Increasing government funding for proteomics and genomics research to drive market
- 18.3.4 ITALY
- 18.3.4.1 Increasing life sciences research to propel market
- 18.3.5 SPAIN
- 18.3.5.1 Growing chemicals industry to support market growth
- 18.3.6 REST OF EUROPE
- 18.3.1 GERMANY
- 18.4 ASIA PACIFIC
- 18.4.1 CHINA
- 18.4.1.1 Increasing international pressure to ban animal testing methods to propel the market
- 18.4.2 JAPAN
- 18.4.2.1 Rising demand for technologically advanced research products to drive market
- 18.4.3 INDIA
- 18.4.3.1 Growing focus of universities on avoiding animal testing for cosmetic products to propel the market
- 18.4.4 SOUTH KOREA
- 18.4.4.1 Growing government focus on boosting pharmaceutical spending to propel market growth
- 18.4.5 AUSTRALIA
- 18.4.5.1 Growing pharmaceutical research to help market growth
- 18.4.6 REST OF ASIA PACIFIC
- 18.4.1 CHINA
- 18.5 LATIN AMERICA
- 18.5.1 BRAZIL
- 18.5.1.1 Adoption of non-animal testing methods to propel market
- 18.5.2 MEXICO
- 18.5.2.1 Ban on animal testing for cosmetics to support market growth
- 18.5.3 REST OF LATIN AMERICA
- 18.5.1 BRAZIL
- 18.6 MIDDLE EAST
- 18.6.1 GCC COUNTRIES
- 18.6.1.1 Saudi Arabia
- 18.6.1.1.1 Rising pharmaceutical R&D activities and regulatory focus on alternative testing methods to support market growth
- 18.6.1.2 United Arab Emirates (UAE)
- 18.6.1.2.1 Expanding biotechnology ecosystem and growing focus on advanced safety assessment technologies supporting market growth
- 18.6.1.3 Rest of GCC Countries
- 18.6.1.4 Rest of Middle East
- 18.6.1.1 Saudi Arabia
- 18.6.2 AFRICA
- 18.6.2.1 Precision medicine initiatives to fuel market growth
- 18.6.1 GCC COUNTRIES
19 COMPETITIVE LANDSCAPE
- 19.1 OVERVIEW
- 19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET
- 19.3 REVENUE SHARE ANALYSIS
- 19.4 MARKET SHARE ANALYSIS
- 19.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 19.5.1 STARS
- 19.5.2 EMERGING LEADERS
- 19.5.3 PERVASIVE PLAYERS
- 19.5.4 PARTICIPANTS
- 19.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 19.5.5.1 Company footprint
- 19.5.5.2 Region footprint
- 19.5.5.3 Offering footprint
- 19.5.5.4 Technology footprint
- 19.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 19.6.1 PROGRESSIVE COMPANIES
- 19.6.2 STARTING BLOCKS
- 19.6.3 RESPONSIVE COMPANIES
- 19.6.4 DYNAMIC COMPANIES
- 19.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
- 19.6.5.1 Competitive benchmarking of key startups/SMEs
- 19.7 COMPANY VALUATION & FINANCIAL METRICS
- 19.7.1 FINANCIAL METRICS
- 19.7.2 COMPANY VALUATION
- 19.8 BRAND/PRODUCT COMPARISON
- 19.9 COMPETITIVE SCENARIO
- 19.9.1 PRODUCT LAUNCHES
- 19.9.2 DEALS
- 19.9.3 EXPANSIONS
20 COMPANY PROFILES
- 20.1 THERMO FISHER SCIENTIFIC INC.
- 20.1.1 BUSINESS OVERVIEW
- 20.1.1.1 Products/Services/Solutions offered
- 20.1.1.2 Recent developments
- 20.1.1.2.1 Product launches
- 20.1.1.2.2 Deals
- 20.1.1.2.3 Expansions
- 20.1.1.3 MnM view
- 20.1.1.3.1 Key strengths
- 20.1.1.3.2 Strategic choices
- 20.1.1.3.3 Weaknesses and competitive threats
- 20.1.2 AGILENT TECHNOLOGIES, INC.
- 20.1.2.1 Business overview
- 20.1.2.2 Products/Services/Solutions offered
- 20.1.2.3 Recent developments
- 20.1.2.3.1 Product launches & enhancements
- 20.1.2.3.2 Deals
- 20.1.2.4 MnM view
- 20.1.2.4.1 Key strengths
- 20.1.2.4.2 Strategic choices
- 20.1.2.4.3 Weaknesses and competitive threats
- 20.1.3 MERCK KGAA
- 20.1.3.1 Business overview
- 20.1.3.2 Products/Services/Solutions offered
- 20.1.3.3 Recent developments
- 20.1.3.3.1 Deals
- 20.1.3.4 MnM view
- 20.1.3.4.1 Key strengths
- 20.1.3.4.2 Strategic choices
- 20.1.3.4.3 Weaknesses and competitive threats
- 20.1.4 EUROFINS SCIENTIFIC
- 20.1.4.1 Business overview
- 20.1.4.2 Products/Services/Solutions offered
- 20.1.4.3 Recent developments
- 20.1.4.3.1 Expansions
- 20.1.5 CHARLES RIVER LABORATORIES
- 20.1.5.1 Business overview
- 20.1.5.2 Products/Services/Solutions offered
- 20.1.5.3 Recent developments
- 20.1.5.3.1 Product launches
- 20.1.5.3.2 Deals
- 20.1.5.3.3 Other developments
- 20.1.5.4 MnM view
- 20.1.5.4.1 Key strengths
- 20.1.5.4.2 Strategic choices
- 20.1.5.4.3 Weaknesses and competitive threats
- 20.1.6 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 20.1.6.1 Business overview
- 20.1.6.2 Products/Services/Solutions offered
- 20.1.6.3 Recent developments
- 20.1.6.3.1 Deals
- 20.1.6.3.2 Expansions
- 20.1.6.3.3 Other developments
- 20.1.6.4 MnM view
- 20.1.6.4.1 Key strengths
- 20.1.6.4.2 Strategic choices
- 20.1.6.4.3 Weaknesses and competitive threats
- 20.1.7 SGS SA
- 20.1.7.1 Business overview
- 20.1.7.2 Products/Services/Solutions offered
- 20.1.7.3 Recent developments
- 20.1.7.3.1 Deals
- 20.1.7.3.2 Expansions
- 20.1.8 LONZA
- 20.1.8.1 Business overview
- 20.1.8.2 Products/Services/Solutions offered
- 20.1.9 REVVITY
- 20.1.9.1 Business overview
- 20.1.9.2 Products/Services/Solutions offered
- 20.1.9.3 Recent developments
- 20.1.9.3.1 Product launches
- 20.1.9.3.2 Other developments
- 20.1.10 BIO-RAD LABORATORIES, INC.
- 20.1.10.1 Business overview
- 20.1.10.2 Products/Services/Solutions offered
- 20.1.10.3 Recent developments
- 20.1.10.3.1 Product launches
- 20.1.10.3.2 Deals
- 20.1.11 EVOTEC SE
- 20.1.11.1 Business overview
- 20.1.11.2 Products/Services/Solutions offered
- 20.1.11.3 Recent developments
- 20.1.11.3.1 Deals
- 20.1.11.3.2 Other developments
- 20.1.12 NOVO HOLDINGS
- 20.1.12.1 Business overview
- 20.1.12.2 Products & services offered
- 20.1.13 INTERTEK GROUP PLC
- 20.1.13.1 Business overview
- 20.1.13.2 Products & services offered
- 20.1.14 INOTIV
- 20.1.14.1 Business overview
- 20.1.14.2 Products & services offered
- 20.1.15 PROMEGA CORPORATION
- 20.1.15.1 Business overview
- 20.1.15.2 Products & services offered
- 20.1.15.3 Recent developments
- 20.1.15.3.1 Deals
- 20.1.1 BUSINESS OVERVIEW
- 20.2 OTHER PLAYERS
- 20.2.1 BIOIVT
- 20.2.2 CREATIVE BIOLABS
- 20.2.3 MEDICILON
- 20.2.4 CREATIVE BIOARRAY
- 20.2.5 ARAGEN LIFE SCIENCES LTD.
- 20.2.6 ENZO BIOCHEM INC.
- 20.2.7 MICROBAC LABORATORIES, INC.
- 20.2.8 VIMTA LABS LTD.
- 20.2.9 PACIFIC BIOLABS, INC.
- 20.2.10 MB RESEARCH LABORATORIES
21 RESEARCH METHODOLOGY
- 21.1 RESEARCH DATA
- 21.1.1 SECONDARY DATA
- 21.1.2 PRIMARY DATA
- 21.2 MARKET SIZE ESTIMATION
- 21.2.1 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET ESTIMATION, 2025
- 21.2.1.1 Key industry insights
- 21.2.1 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET ESTIMATION, 2025
- 21.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
- 21.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 21.5 RESEARCH ASSUMPTIONS
- 21.6 RESEARCH LIMITATIONS
- 21.7 RISK ANALYSIS
22 APPENDIX
- 22.1 DISCUSSION GUIDE
- 22.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 22.3 CUSTOMIZATION OPTIONS
- 22.4 RELATED REPORTS
- 22.5 AUTHOR DETAILS
List of Tables
- TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS
- TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 3 IN VITRO TOXICOLOGY TESTING MARKET: ROLE IN ECOSYSTEM
- TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
- TABLE 5 INDICATIVE SELLING PRICE, BY REGION, 2025
- TABLE 6 IN VITRO TOXICOLOGY TESTING MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 8 INDICATIVE LIST OF PATENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026
- TABLE 9 CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET
- TABLE 10 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET
- TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 15 COUNTRY-WISE REGULATORY SCENARIO FOR IN VITRO TOXICOLOGY TESTING PRODUCT & SERVICE PROVIDERS
- TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
- TABLE 17 KEY BUYING CRITERIA, BY END USER
- TABLE 18 IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031(USD MILLION)
- TABLE 19 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024-2031(USD MILLION)
- TABLE 20 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 21 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 22 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 23 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 24 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024-2031(USD MILLION)
- TABLE 25 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031(USD MILLION)
- TABLE 27 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 28 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 29 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 30 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 31 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031(USD MILLION)
- TABLE 32 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031(USD MILLION)
- TABLE 33 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 34 IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 35 NORTH AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 EUROPE: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 37 ASIA PACIFIC: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 LATIN AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 MIDDLE EAST: IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 40 GCC COUNTRIES: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 IVTT REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 42 CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 43 NORTH AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 44 EUROPE: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 ASIA PACIFIC: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 LATIN AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 MIDDLE EAST: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 48 GCC COUNTRIES: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 50 NORTH AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 EUROPE: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 52 ASIA PACIFIC: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 LATIN AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 MIDDLE EAST: 3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 55 GCC COUNTRIES: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 57 NORTH AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 58 EUROPE: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 ASIA PACIFIC: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 LATIN AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 MIDDLE EAST: CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 62 GCC COUNTRIES: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 64 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 69 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 IVTT ASSAY KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 71 NORTH AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 72 EUROPE: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 ASIA PACIFIC: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 74 LATIN AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 MIDDLE EAST: IVTT ASSAY KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 76 GCC COUNTRIES: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 IVTT ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 78 ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 79 NORTH AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 EUROPE: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 81 ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 LATIN AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 MIDDLE EAST: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 84 GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 85 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 86 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 87 EUROPE: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 88 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 91 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 GENOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 93 NORTH AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 EUROPE: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 95 ASIA PACIFIC: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 LATIN AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 MIDDLE EAST: GENOTOXICITY ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 98 GCC COUNTRIES: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 OTHER ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 100 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 101 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 MIDDLE EAST: OTHER ASSAYS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 105 GCC COUNTRIES: OTHER ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 IVTT EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 107 NORTH AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 108 EUROPE: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 ASIA PACIFIC: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 LATIN AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 MIDDLE EAST: IVTT EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 112 GCC COUNTRIES: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 IVTT EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 114 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 120 GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 122 DETECTION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 123 NORTH AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 EUROPE: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 ASIA PACIFIC: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 LATIN AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 MIDDLE EAST: DETECTION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 128 GCC COUNTRIES: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 129 IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 130 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 131 EUROPE: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 MIDDLE EAST: IMAGING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 135 GCC COUNTRIES: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 137 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 142 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 143 LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 144 NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 147 LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 149 GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 150 OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 151 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 152 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 156 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 158 NORTH AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 159 EUROPE: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 ASIA PACIFIC: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 161 LATIN AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 MIDDLE EAST: IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 163 GCC COUNTRIES: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 165 ORGAN TOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 EUROPE: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 168 ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 171 GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 173 HEPATOTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 174 NORTH AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 EUROPE: HEPATOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 ASIA PACIFIC: HEPATOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 LATIN AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 178 MIDDLE EAST: HEPATOTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 179 GCC COUNTRIES: HEPATOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 180 OCULAR TOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 181 NORTH AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 182 EUROPE: OCULAR TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 ASIA PACIFIC: OCULAR TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 LATIN AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 185 MIDDLE EAST: OCULAR TOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 186 GCC COUNTRIES: OCULAR TOXICITY MARKET, BY COUNTRY , 2024-2031 (USD MILLION)
- TABLE 187 CARDIOTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 188 NORTH AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 EUROPE: CARDIOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 190 ASIA PACIFIC: CARDIOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 LATIN AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 192 MIDDLE EAST: CARDIOTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 193 GCC COUNTRIES: CARDIOTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 NEUROTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 195 NORTH AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 EUROPE: NEUROTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 197 ASIA PACIFIC: NEUROTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 LATIN AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 199 MIDDLE EAST: NEUROTOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 200 GCC COUNTRIES: NEUROTOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 201 OTHER TOXICITY END POINTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 202 NORTH AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 EUROPE: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 ASIA PACIFIC: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 LATIN AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 206 MIDDLE EAST: OTHER TOXICITY END POINTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 207 GCC COUNTRIES: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 208 CYTOTOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 209 NORTH AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 210 EUROPE: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 ASIA PACIFIC: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 212 LATIN AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 MIDDLE EAST: CYTOTOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 214 GCC COUNTRIES: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 215 DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 216 NORTH AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 EUROPE: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 ASIA PACIFIC: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 LATIN AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 MIDDLE EAST: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 221 GCC COUNTRIES: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 222 GENOTOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 223 NORTH AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 224 EUROPE: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 ASIA PACIFIC: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 LATIN AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 MIDDLE EAST: GENOTOXICITY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 228 GCC COUNTRIES: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 230 NORTH AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 EUROPE: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 ASIA PACIFIC: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 LATIN AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 234 MIDDLE EAST: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 235 GCC COUNTRIES: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 237 NORTH AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 238 EUROPE: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 ASIA PACIFIC: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 LATIN AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 MIDDLE EAST: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 242 GCC COUNTRIES: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 243 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 244 CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 245 NORTH AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 246 EUROPE: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 ASIA PACIFIC: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 LATIN AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 MIDDLE EAST: CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 250 GCC COUNTRIES: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 252 NORTH AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 253 EUROPE: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 ASIA PACIFIC: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 LATIN AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 MIDDLE EAST: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 257 GCC COUNTRIES: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 259 NORTH AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 260 EUROPE: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 261 ASIA PACIFIC: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 262 LATIN AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 MIDDLE EAST: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 264 GCC COUNTRIES: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 265 OMICS TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 266 NORTH AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 267 EUROPE: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 268 ASIA PACIFIC: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 269 LATIN AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 MIDDLE EAST: OMICS TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 271 GCC COUNTRIES: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 OTHER TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 273 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 274 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 275 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 276 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 277 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 278 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 280 CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 281 NORTH AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 282 EUROPE: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 ASIA PACIFIC: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 284 LATIN AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 MIDDLE EAST: CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 286 GCC COUNTRIES: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 287 BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 288 NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 289 EUROPE: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 291 LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 292 MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 293 GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 294 MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 295 NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 296 EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 297 ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 298 LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 299 MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 300 GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 301 EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 302 NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 303 EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 304 ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 305 LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 306 MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 307 GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 308 IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 309 NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 310 EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 311 ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 312 LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 313 MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 314 GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 315 OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 316 NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 317 EUROPE: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 318 ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 319 LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 320 MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 321 GCC COUNTRIES: OTHER METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 322 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 323 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 324 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 325 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 326 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 327 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 328 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 329 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 330 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 331 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 332 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 333 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 334 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 335 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 336 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 337 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 338 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 339 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 340 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 341 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 342 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 343 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 344 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 345 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 346 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 347 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 348 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 349 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 350 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 351 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 352 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 353 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 354 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 355 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 356 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 357 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 358 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 359 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 360 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 361 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 362 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 363 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 364 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 365 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 366 TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 367 NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 368 EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 369 ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 370 LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 371 MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 372 GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 373 TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 374 ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 375 NORTH AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 376 EUROPE: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 377 ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 378 LATIN AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 379 MIDDLE EAST: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 380 GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 381 CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 382 NORTH AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 383 EUROPE: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 384 ASIA PACIFIC: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 385 LATIN AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 386 MIDDLE EAST: CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 387 GCC COUNTRIES: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 388 GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 389 NORTH AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 390 EUROPE: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 391 ASIA PACIFIC: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 392 LATIN AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 393 MIDDLE EAST: GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 394 GCC COUNTRIES: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 395 OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 396 NORTH AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 397 EUROPE: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 398 ASIA PACIFIC: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 399 LATIN AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 400 MIDDLE EAST: OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 401 GCC COUNTRIES: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 402 BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 403 NORTH AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 404 EUROPE: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 405 ASIA PACIFIC: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 406 LATIN AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 407 MIDDLE EAST: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 408 GCC COUNTRIES: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 409 IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 410 NORTH AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 411 EUROPE: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 412 ASIA PACIFIC: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 413 LATIN AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 414 MIDDLE EAST: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 415 GCC COUNTRIES: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 416 DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 417 NORTH AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 418 EUROPE: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 419 ASIA PACIFIC: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 420 LATIN AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 421 MIDDLE EAST: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 422 GCC COUNTRIES: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 423 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 424 CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 425 NORTH AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 426 EUROPE: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 427 ASIA PACIFIC: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 428 LATIN AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 429 MIDDLE EAST: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 430 GCC COUNTRIES: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 431 BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 432 NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 433 EUROPE: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 434 ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 435 LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 436 MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 437 GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 438 IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 439 NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 440 EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 441 ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 442 LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 443 MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 444 GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 445 MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 446 NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 447 EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 448 ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 449 LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 450 MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 451 GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 452 EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 453 NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 454 EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 455 ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 456 LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 457 MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 458 GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 459 OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 460 NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 461 EUROPE: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 462 ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 463 LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 464 MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 465 GCC COUNTRIES: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 466 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 467 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 468 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 469 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 470 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 471 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 472 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 473 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 474 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 475 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 476 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 477 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 478 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 479 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 480 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 481 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 482 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 483 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 484 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 485 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 486 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 487 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 488 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 489 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 490 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 491 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 492 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 493 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 494 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 495 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 496 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 497 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 498 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 499 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 500 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 501 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 502 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 503 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 504 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 505 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 506 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 511 NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 513 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 514 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 515 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 516 NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 517 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 518 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 519 US: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 520 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 521 US: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 US: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 US: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 US: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 526 US: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 528 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 529 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 530 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 531 US: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 532 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 533 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 534 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 535 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 536 CANADA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 CANADA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 CANADA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 CANADA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 541 CANADA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 543 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 544 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 545 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 546 CANADA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 547 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 548 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 549 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 550 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 551 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 553 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 557 EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 558 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 559 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 560 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 561 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE , 2024-2031 (USD MILLION)
- TABLE 562 EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 563 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 564 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 565 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 566 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 567 GERMANY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 568 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 569 GERMANY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 GERMANY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 572 GERMANY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 573 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 574 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 575 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 576 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 577 GERMANY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 578 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 579 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 580 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 581 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 582 UK: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 583 UK: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 584 UK: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 585 UK: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 586 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 587 UK: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 588 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 589 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 590 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 591 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 592 UK: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 593 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 594 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 595 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 596 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 597 FRANCE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 598 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 599 FRANCE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 600 FRANCE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 601 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 602 FRANCE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 603 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 604 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 605 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 606 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 607 FRANCE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 608 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 609 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 610 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 611 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 612 ITALY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 613 ITALY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE , 2024-2031 (USD MILLION)
- TABLE 614 ITALY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 615 ITALY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 616 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 617 ITALY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 618 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 619 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 620 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 621 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 622 ITALY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 623 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 624 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 625 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 626 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 627 SPAIN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 628 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 629 SPAIN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 630 SPAIN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 631 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 632 SPAIN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 633 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 634 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 635 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 636 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 637 SPAIN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 638 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 639 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 640 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 641 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 642 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 643 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 644 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 645 REST OF EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 646 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 647 REST OF EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 648 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 649 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 650 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 651 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 652 REST OF EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 653 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 654 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 655 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 656 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 657 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 658 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 659 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 660 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 661 ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 662 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 663 ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 664 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 665 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 666 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 667 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 668 ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 669 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 670 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 671 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 672 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 673 CHINA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 674 CHINA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 675 CHINA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 676 CHINA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 677 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 678 CHINA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 679 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 680 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 681 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 682 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 683 CHINA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 684 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 685 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 686 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 687 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 688 JAPAN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 689 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 690 JAPAN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 691 JAPAN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 692 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 693 JAPAN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 694 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 695 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 696 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 697 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 698 JAPAN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 699 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 700 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 701 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 702 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 703 INDIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 704 INDIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 705 INDIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 706 INDIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 707 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 708 INDIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 709 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 710 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 711 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 712 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 713 INDIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 714 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 715 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 716 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 717 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 718 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 719 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 720 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 721 SOUTH KOREA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 722 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 723 SOUTH KOREA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 724 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 725 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 726 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 727 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 728 SOUTH KOREA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 729 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 730 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 731 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 732 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 733 AUSTRALIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 734 AUSTRALIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 735 AUSTRALIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 736 AUSTRALIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 737 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 738 AUSTRALIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 739 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 740 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 741 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 742 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 743 AUSTRALIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 744 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 745 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 746 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 747 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 748 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 749 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 750 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 751 REST OF ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 752 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 753 REST OF ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 754 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 755 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 756 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 757 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 758 REST OF ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 759 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 760 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 761 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 762 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 763 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 764 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 765 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 766 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 767 LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 768 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 769 LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 770 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 771 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 772 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 773 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 774 LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 775 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 776 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 777 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 778 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 779 BRAZIL: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 780 BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 781 BRAZIL: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE , 2024-2031 (USD MILLION)
- TABLE 782 BRAZIL: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 783 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 784 BRAZIL: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 785 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 786 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 787 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 788 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 789 BRAZIL: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 790 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 791 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 792 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 793 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 794 MEXICO: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 795 MEXICO: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 796 MEXICO: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 797 MEXICO: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 798 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 799 MEXICO: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 800 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 801 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 802 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 803 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 804 MEXICO: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 805 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 806 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 807 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 808 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 809 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 810 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 811 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 812 REST OF LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 813 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 814 REST OF LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 815 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 816 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 817 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 818 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 819 REST OF LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 820 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 821 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 822 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 823 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 824 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 825 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 826 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 827 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 828 MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 829 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 830 MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 831 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 832 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 833 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 834 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 835 MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 836 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 837 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 838 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 839 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 840 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 841 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 842 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 843 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 844 GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 845 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 846 GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 847 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 848 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 849 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 850 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 851 GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 852 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 853 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 854 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 855 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 856 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 857 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 858 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 859 SAUDI ARABIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 860 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 861 SAUDI ARABIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 862 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 863 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 864 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 865 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 866 SAUDI ARABIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 867 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 868 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 869 UAE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 870 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 871 UAE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 872 UAE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 873 UAE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 874 UAE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 875 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 876 UAE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 877 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 878 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 879 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 880 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 881 UAE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 882 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 883 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 884 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 885 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 886 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 887 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 888 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 889 REST OF GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 890 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 891 REST OF GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 892 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 893 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 894 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 895 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 896 REST OF GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 897 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 898 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 899 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 900 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 901 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 902 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 903 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 904 REST OF MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 905 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 906 REST OF MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 907 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 908 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 909 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 910 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 911 REST OF MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 912 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 913 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 914 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 915 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 916 AFRICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 917 AFRICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 918 AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 919 AFRICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 920 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024-2031 (USD MILLION)
- TABLE 921 AFRICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 922 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 923 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 924 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 925 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 926 AFRICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 927 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 928 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 929 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET
- TABLE 930 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
- TABLE 931 IN VITRO TOXICOLOGY TESTING MARKET: REGION FOOTPRINT (2025)
- TABLE 932 IN VITRO TOXICOLOGY TESTING MARKET: OFFERING FOOTPRINT (2025)
- TABLE 933 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET: TECHNOLOGY FOOTPRINT (2025
- TABLE 934 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 935 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION
- TABLE 936 IN VITRO TOXICOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 937 HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023-APRIL 2026
- TABLE 938 HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 939 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 940 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 941 THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 942 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 943 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 944 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 945 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 946 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-APRIL 2026
- TABLE 947 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 948 MERCK KGAA: COMPANY OVERVIEW
- TABLE 949 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 950 MERCK KGAA: DEALS, JANUARY 2023-APRIL 2026
- TABLE 951 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 952 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 953 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 954 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
- TABLE 955 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 956 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 957 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023-APRIL 2026
- TABLE 958 CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 959 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
- TABLE 960 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 961 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2023-APRIL 2026
- TABLE 962 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 963 LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 964 SGS SA: COMPANY OVERVIEW
- TABLE 965 SGS SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 966 SGS SA: DEALS, JANUARY 2023-APRIL 2026
- TABLE 967 SGS SA: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 968 LONZA: COMPANY OVERVIEW
- TABLE 969 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 970 REVVITY: COMPANY OVERVIEW
- TABLE 971 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 972 REVVITY: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 973 REVVITY: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 974 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 975 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 976 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 977 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 978 EVOTEC SE: COMPANY OVERVIEW
- TABLE 979 EVOTEC SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 980 EVOTEC SE: DEALS, JANUARY 2023-APRIL 2026
- TABLE 981 LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 982 NOVO HOLDINGS: BUSINESS OVERVIEW
- TABLE 983 INTERTEK GROUP PLC: BUSINESS OVERVIEW
- TABLE 984 INOTIV: BUSINESS OVERVIEW
- TABLE 985 PROMEGA CORPORATION: BUSINESS OVERVIEW
- TABLE 986 PROMEGA CORPORATION: DEALS, JANUARY 2023-APRIL 2026
- TABLE 987 BIOIVT: COMPANY OVERVIEW
- TABLE 988 CREATIVE BIOLABS: COMPANY OVERVIEW
- TABLE 989 MEDICILON: COMPANY OVERVIEW
- TABLE 990 CREATIVE BIOARRAY: COMPANY OVERVIEW
- TABLE 991 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
- TABLE 992 ENZO BIOCHEM INC.: COMPANY OVERVIEW
- TABLE 993 MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 994 VIMTA LABS LTD.: COMPANY OVERVIEW
- TABLE 995 PACIFIC BIOLABS, INC.: COMPANY OVERVIEW
- TABLE 996 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
- TABLE 997 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
List of Figures
- FIGURE 1 MARKET SCENARIO
- FIGURE 2 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, 2024-2031
- FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2023-2026
- FIGURE 4 DISRUPTIONS INFLUENCING THE GROWTH OF IN VITRO TOXICOLOGY TESTING MARKET
- FIGURE 5 HIGH-GROWTH SEGMENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026-2031
- FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 7 SHIFT TOWARDS NON-ANIMAL TOXICOLOGY TESTING METHODS TO DRIVE MARKET GROWTH
- FIGURE 8 REAGENTS & CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET IN NORTH AMERICA IN 2025
- FIGURE 9 ASIA PACIFIC IS LIKELY TO BE THE FASTEST-GROWING REGIONAL MARKET DURING THE FORECAST PERIOD
- FIGURE 10 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
- FIGURE 13 IN VITRO TOXICOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
- FIGURE 14 IN VITRO TOXICOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
- FIGURE 15 IN VITRO TOXICOLOGY TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 16 TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015-2025
- FIGURE 17 IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET
- FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 19 KEY BUYING CRITERIA, BY END USER
- FIGURE 20 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
- FIGURE 21 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
- FIGURE 23 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025
- FIGURE 24 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 25 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY FOOTPRINT
- FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 27 EV/EBITDA OF KEY VENDORS
- FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 29 IN VITRO TOXICITY TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
- FIGURE 34 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025)
- FIGURE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2025)
- FIGURE 36 SGS SA: COMPANY SNAPSHOT (2025)
- FIGURE 37 LONZA: COMPANY SNAPSHOT (2025)
- FIGURE 38 REVVITY: COMPANY SNAPSHOT (2025)
- FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 40 EVOTEC SE: COMPANY SNAPSHOT (2025)
- FIGURE 41 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2025)
- FIGURE 42 INOTIV: COMPANY SNAPSHOT (2025)
- FIGURE 43 RESEARCH DESIGN
- FIGURE 44 IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 45 IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
- FIGURE 46 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2025
- FIGURE 47 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2025
- FIGURE 48 IVTT MARKET: INSIGHTS FROM PRIMARIES
- FIGURE 49 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 50 IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS
- FIGURE 51 IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
- FIGURE 52 DATA TRIANGULATION METHODOLOGY
02-2729-4219
+886-2-2729-4219
體外毒性測試市場規模、佔有率和成長分析：按方法、技術、應用、最終用戶和地區分類－2026-2033年產業預測
生殖毒性測試市場預測至2034年－按產品、方法、技術、最終用戶和地區分類的全球分析皮膚毒性測試市場預測至2034年—按類型、測試方法、測試類別、最終用戶和地區分類的全球分析
體外毒性測試市場：依服務類型、技術、應用和最終用戶分類－2026-2032年全球市場預測
體外毒性測試市場：按類型、最終用戶和地區分類
全球體外毒性測試市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
遺傳毒性檢測市場分析及預測（至2035年）：類型、產品類型、服務、技術、組件、應用、最終用戶、流程、解決方案和階段全球體外毒性測試市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
皮膚毒性測試市場－全球產業規模、佔有率、趨勢、機會與預測：測試類型、測試方法類型、最終用戶、地區和競爭格局，2021-2031年體外毒理學測試市場－全球產業規模、佔有率、趨勢、機會和預測，按技術、應用、方法、最終用戶、地區和競爭細分，2020 年至 2030 年
▼